EUVIMEDEUVIMED entdecken
Crossref

Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors?

Alice Dewdney and Sarah Needleman

Clinical Medicine Reviews in Oncology · 2010

DOI: 10.4137/cmro.s4203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2010. Verfasst von Alice Dewdney and Sarah Needleman.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Needleman, A. D. A. S. (2010). Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors?. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s4203

Vancouver

Needleman ADAS. Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors?. Clinical Medicine Reviews in Oncology. 2010. doi:10.4137/cmro.s4203

BibTeX
@article{Needleman2010,
  author = {Needleman, Alice Dewdney and Sarah},
  title = {Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors?},
  journal = {Clinical Medicine Reviews in Oncology},
  year = {2010},
  doi = {10.4137/cmro.s4203}
}
Kostenlos starten →